Russell Diez-Canseco - May 12, 2025 Form 4 Insider Report for Vital Farms, Inc. (VITL)

Signature
/s/ Francis Cullo, Attorney-in-Fact
Stock symbol
VITL
Transactions as of
May 12, 2025
Transactions value $
-$1,162,985
Form type
4
Date filed
5/14/2025, 05:00 PM
Previous filing
Apr 16, 2025
Next filing
May 27, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Diez-Canseco Russell PRESIDENT AND CEO, Director C/O VITAL FARMS, INC., 3601 SOUTH CONGRESS AVENUE, SUITE C100, AUSTIN /s/ Francis Cullo, Attorney-in-Fact 2025-05-14 0001818591

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VITL Common Stock Options Exercise $210K +39.4K +5.61% $5.33 743K May 12, 2025 Direct
transaction VITL Common Stock Options Exercise $167K +13.1K +1.76% $12.81 756K May 12, 2025 Direct
transaction VITL Common Stock Sale -$1.15M -33.9K -4.48% $33.98 722K May 12, 2025 Direct F1, F2
transaction VITL Common Stock Sale -$389K -11.3K -1.56% $34.55 711K May 12, 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VITL Employee Stock Option (right to buy) Options Exercise $0 -39.4K -100% $0.00 0 May 12, 2025 Common Stock 39.4K $5.33 Direct F4
transaction VITL Employee Stock Option (right to buy) Options Exercise $0 -13.1K -32.79% $0.00 26.7K May 12, 2025 Common Stock 13.1K $12.81 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.48 to $34.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.49 to $34.67 inclusive.
F4 Fully vested.